News & Updates

Early initiation of rhythm control for atrial fibrillation (AF) appears to be favourable, but women should start rhythm control treatment earlier than men to get the best possible outcomes, according to a study presented at the annual meeting of the European Heart Rhythm Association (EHRA).

Renal renin‒angiotensin system (RAS) appears to contribute to renal arteriolar remodeling and future decline in estimated glomerular filtration rate (eGFR), irrespective of potential risk factors, in patients with chronic kidney disease (CKD), a study has found.

Antihypertensive treatment provides benefits on left ventricular (LV) mechanisms, suggest the results of a meta-analysis, noting that improvement in global longitudinal strain (GLS) is associated with the reduction in LV mass index (LVMI) instead of systolic blood pressure (SBP).

In patients who had received catheter ablation for atrial fibrillation, left atrial deformation analysis can help assess the risk of atrial tachyarrhythmia recurrence, reports a new study.

Pacemaker is not inferior to implantable cardiac defibrillator (ICD) device in terms of survival for heart failure (HF), according to the RESET-CRT study presented at EHRA 2022 — thus raising the question on the need of defibrillation in CRT for these patients.

Residual inflammation is a strong predictor of recurrent cardiovascular (CV) events than hyperlipidaemia in patients with atherosclerotic disease and impaired kidney function in a sub-study of the CANTOS* trial.